Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method possibilities remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover https://financefeeds.com/sterling-trading-tech-adds-chris-contrino-to-business-development-team/